Director Christopher J. Policinski filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 2,792.0962 stock units in Corteva, Inc. (NYSE:CTVA) on October 30, 2026, through the company's director deferred compensation plan.

Key Highlights

  • Transaction date: October 30, 2026, with 2,792.0962 stock units acquired via transaction code "A."
  • Price used: Units were calculated at $11.64 per share, the closing price of CTVA common stock on the date the cash compensation would otherwise have been payable.
  • Deferred compensation plan: The acquisition was made under Corteva's Stock Accumulation and Deferred Compensation Plan for Directors, which allows non-employee directors to defer cash compensation into stock units settled in common stock on a future date.
  • Post-transaction holdings: Policinski beneficially owned 5,565.676 shares of common stock directly following the reported transaction, including 5.0846 shares acquired through dividend reinvestment.
  • Role: Policinski is identified as a Director of Corteva, Inc., with no officer title indicated.

Policinski's October 2026 Director Pay Deferral at Corteva

According to the filing, Christopher J. Policinski, a non-employee director of Corteva, Inc. (NYSE:CTVA), acquired 2,792.0962 stock units on October 30, 2026, under the issuer's Stock Accumulation and Deferred Compensation Plan for Directors. The filing states that under this plan, non-employee directors may elect to defer all or a specified portion of their cash compensation, to be settled in CTVA common stock on a one-for-one basis on a future date selected by the director at the time of the deferral election.

The filing discloses that cash compensation deferred in the form of stock units is calculated based on the closing price of CTVA common stock on the date the cash compensation would have otherwise been payable, which in this case was $11.64 per share. The units are categorized as an acquisition (code "A") in Table I covering non-derivative securities.

Following the reported transaction, the filing reports that Policinski directly held 5,565.676 shares of Corteva common stock in total. The filing notes this figure includes 5.0846 shares acquired pursuant to dividend reinvestment. The Form 4 was signed by Abigail Jarrell under power of attorney and filed on November 3, 2026.

What Was Disclosed

The filing disclosed a director deferred compensation transaction by Christopher J. Policinski at Corteva, Inc., covering the acquisition of 2,792.0962 stock units at $11.64 per unit on October 30, 2026, resulting in total direct beneficial ownership of 5,565.676 shares.